Mediplantex National Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, revenue was VND 175,950.57 million compared to VND 197,548.17 million a year ago. Net loss was VND 1,573.49 million compared to net income of VND 4,759.82 million a year ago. Basic loss per share from continuing operations was VND 127 compared to basic earnings per share from continuing operations of VND 758 a year ago.